SCHNEIDER CAPITAL MANAGEMENT CORP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
SCHNEIDER CAPITAL MANAGEMENT CORP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2017$1,615,000
+6.4%
181,900
+51.6%
0.29%
+0.7%
Q2 2017$1,518,000
+141.0%
119,973
+100.0%
0.29%
+175.2%
Q1 2017$630,000
+52.2%
59,973
+33.4%
0.10%
+47.9%
Q4 2016$414,00044,9730.07%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders